October 18, 2018
International Soft Landing Assistance
BioHealth Innovation, Inc. (BHI) provides international companies the perfect starting point to create or locate US-based…
October 17, 2018
325th Edition – October 16, 2018
BioHealth Innovation If you are having trouble viewing this email, please click here October 16,…
October 15, 2018
MaxCyte commences dosing in its first clinical trial using its CARMA™ (CAR therapeutic) autologous cell-therapy platform
MaxCyte, the global cell-based medicines and life sciences company, announced today that the first patient…
October 15, 2018
La Petite Noiseuse Productions Co-Founder and Chief Science and Art Officer Monica Lopez, PhD joins Rich Bendis on BioTalk
Correction: This story originally published on 10/16 included a 2nd paragraph referencing a previous guest…
October 15, 2018
Qiagen and Women in Bio Recognized at 5th Annual BioBowl
More than 300 representatives of companies from throughout the BioHealth Capital Region took over BowlMore…
October 15, 2018
Women Building Bio 2018 – Virginia Bio
Have you register for this year’s Women Building Bio event? The third Annual Women Building…
October 15, 2018
Lupin receives tentative FDA approval for generic Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg and 120 mg
Pharma major Lupin announced that it has received tentative approval for its Lurasidone Hydrochloride Tablets,…
October 15, 2018
FDA again approves record-breaking number of generic drugs
The Food and Drug Administration approved or tentatively approved a record-setting 971 generic drugs in…
October 15, 2018
M-CERSI Cooperative Agreement Grant Renewed by Food and Drug Administration – Center of Excellence in Regulatory Science and Innovation
The University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI) has been…